Pharmaceuticals Acquisitions in Utah

Dômes Pharma has completed the acquisition of SentrX Animal Care, a Salt Lake City–based developer and manufacturer of veterinary ophthalmology and wound-care products built on its patented BioHAnce crosslinked hyaluronic acid technology. The deal expands Dômes Pharma's product capabilities in veterinary ophthalmology and establishes a stronger foothold for the French family-owned group in North America.

Pfizer Inc. agreed to acquire clinical-stage Arena Pharmaceuticals for $100 per share in an all-cash transaction valued at approximately $6.7 billion, creating a wholly owned subsidiary. The acquisition brings Arena's development-stage portfolio — including etrasimod and cardiovascular assets — into Pfizer's Inflammation & Immunology pipeline to accelerate clinical development and expand therapeutic capabilities.